Two Sigma Securities, LLC Soligenix, Inc. Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.4 - $168.0 $8,708 - $3.66 Million	21,772 New	21,772 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.4 - $0.75 $7,995 - $14,991	-19,988 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.61 - $0.75 $12,192 - $14,991	19,988 New	19,988 $15,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.1 $38,802 - $64,670	-58,791 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.9 - $1.31 $52,911 - $77,016	58,791 New	58,791 $62,000
Q1 2021 May 17, 2021	SELL	$1.31 - $2.35 $40,479 - $72,615	-30,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.26 - $2.75 $38,934 - $84,975	30,900 New	30,900 $40,000
Q2 2018 Aug 14, 2018	SELL	$0.92 - $1.91 $13,513 - $28,055	-14,689 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.92 - $2.4 $28,202 - $35,253	14,689 New	14,689 $29,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $127M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.